Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
about
Antizyme inhibitor 2 (AZIN2/ODCp) stimulates polyamine uptake in mammalian cellsMucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells.MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisThe polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationUnbiased functional clustering of gene variants with a phenotypic-linkage networkInitial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines.Knockdown of antizyme inhibitor decreases prostate tumor growth in vivoGene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.
P2860
Q24317020-3EEAC06F-5B13-44A0-B0FF-452184875D40Q33403662-380CB0A6-5977-4AF1-8554-B32F32C3D912Q33694015-3D35B5AF-299C-4EEC-8584-DDD5193316F9Q33745941-77CDE5CD-F06D-4F74-8AA7-CEF3F30234ACQ33761692-1E1C738B-E797-47FF-8036-82F799FA2FFAQ35233625-6A1429D4-98B4-4226-91AB-E05648E3586DQ36454937-7C26A734-0521-4446-A259-0CFC161CE732Q36638469-6B6DCD91-F751-47A9-B794-0CDDA0350917Q37580229-0C7A9366-A19B-4CF6-8F89-18136927D1D5Q38314726-AA865BDC-51F2-4ED8-9BE0-CE7284635756Q39229600-984DA221-09C0-48A4-A666-620AD85B5303
P2860
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Variation in gene expression p ...... serous ovarian cancer patients
@nl
Variation in gene expression p ...... erous ovarian cancer patients.
@ast
Variation in gene expression p ...... erous ovarian cancer patients.
@en
type
label
Variation in gene expression p ...... serous ovarian cancer patients
@nl
Variation in gene expression p ...... erous ovarian cancer patients.
@ast
Variation in gene expression p ...... erous ovarian cancer patients.
@en
prefLabel
Variation in gene expression p ...... serous ovarian cancer patients
@nl
Variation in gene expression p ...... erous ovarian cancer patients.
@ast
Variation in gene expression p ...... erous ovarian cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Variation in gene expression p ...... erous ovarian cancer patients.
@en
P2093
Aasmund Berner
Ben Davidson
Björn Risberg
Claes G Tropè
Gunnar B Kristensen
Iris Goldberg
Marci E Schaner
Martina Skrede
Reuven Reich
Vered Givant-Horwitz
P2860
P2888
P356
10.1186/1476-4598-4-26
P407
P577
2005-07-21T00:00:00Z
P5875
P6179
1029199662